Information  X 
Enter a valid email address

Standard Life Priv (SLPE)

  Print      Mail a friend       Annual reports

Monday 08 October, 2018

Standard Life Priv

Director/PDMR Shareholding

RNS Number : 3402D
Standard Life Private Eqty Trst PLC
08 October 2018
 

Standard Life Private Equity Trust plc ("the Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

 Peter McKellar

2

 

Reason for the notification

 

a)

 

Position/status

 

PDMR

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Standard Life Private Equity Trust plc

b)

 

LEI

 

2138004MK7VPTZ99EV13

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of 0.2p each

 

 

SLPE

 

b)

 

Nature of the transaction

 

Disposal of Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

340.50p

156,575

338.00p

 

70,000

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

226,575 Ordinary Shares of 0.2p each

 

339.73p

e)

 

Date of the transaction

 

5 and 8 October 2018

f)

 

Place of the transaction

 

London

g)

Name of contact and telephone number for queries

 

Mandy Kelly, Maven Capital Partners UK LLP

Company Secretary (Tel: 0141 206 0124)

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHLLFIRISLTIIT

a d v e r t i s e m e n t